The Indian pharmaceutical sector is going green.
Hyderabad-based pharmaceutical company Granules India has partnered with Greenko Zero for carbon-free energy and green molecule.
In a press release, Granules India said that the partnership will help the company achieve its sustainability and green chemistry goals and develop green molecule solutions for wider applications in the pharmaceutical industry.
The partnership will help develop a carbon-free pharmaceutical manufacturing facility at Kakinada in Andhra Pradesh.
According to the statement, the new facility will be built on 100 acres of land utilizing carbon-free solutions with an expected investment of Rs 2,000 crore over five years. The facility will be based on #sustainabilityprinciples and utilize carbon-free energy and green hydrogen derivatives for large-scale manufacturing of Key Starting Materials (KSM), intermediates, Active Pharma Ingredients (APIs), and fermentation-based products.
The company said that the collaboration allows the utilization of fungible carbon offset instruments across Granule’s global manufacturing locations.
@Dr Krishna Prasad, Chairman and Managing Director, Granules, said in the statement, “Sustainability and green chemistry are key pillars of our commitment to healing the planet and people through minimizing carbonfootprint, adopting resource-efficient processes, and reduce waste across our valuechain.”
Anil Kumar Chalamalasetty, the CEO and Managing Director (MD), Greenko, said, “This partnership will transform industrialmanufacturing to be more sustainable and competitive with technologically superior and green solutions.”
